Electrome
PrivateCompany Overview
Electrome operates in Healthcare & Life Sciences and is based in Los Angeles, California. It was founded in 2025.
Electrome is a therapeutic devices company that has developed a bioelectric therapy platform designed to modulate cellular behavior using electrical signals. The company's platform integrates artificial intelligence-driven modeling, digital twin simulations, and scalable hardware systems for non-invasive treatment delivery for pain, inflammation, infection, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, D2C Brands, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Electrome Comparables
Compare Electrome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| nCAP Medical, Inc. | 79% | |
| BioElectronics Corporation | 78% | |
| Regenesis Biomedical, Inc. | 77% |
For institutional investors. Book with your work email.
Electrome Funding Rounds
Historical fundraising activity
Electrome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Electrome's valuation, stock price, and market status.
Is Electrome a public or private company?
Electrome is a private company.
What is the current stock price of Electrome?
Electrome is a private company, so its shares have no public market price. Caplight tracks Electrome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Electrome worth (valuation)?
Valuation information for Electrome is not publicly available.
Can I buy Electrome stock?
Electrome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Electrome's last funding round?
Funding round information for Electrome is not publicly available.
Who are the main investors in Electrome?
Investor information for Electrome is not publicly disclosed.
Will Electrome IPO soon?
No public IPO plans have been announced for Electrome.
How can I track Electrome secondary market activity?
Caplight tracks bids, offers, and trades in Electrome's shares on secondary markets.